Accessibility Menu
RadNet Stock Quote

RadNet (NASDAQ: RDNT)

$80.94
(3.4%)
+2.63
Price as of November 10, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$80.85
Daily Change
(3.4%) +$2.63
Day's Range
$72.59 - $84.64
Previous Close
$80.85
Open
$77.13
Beta
1.27
Volume
1,574,857
Average Volume
764,203
Market Cap
6B
Market Cap / Employee
$78.31M
52wk Range
$45.00 - $93.65
Revenue
-
Gross Margin
0.04%
Dividend Yield
N/A
EPS
-$0.21
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

RadNet Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
RDNT+9.68%+366.96%+36.05%+18,172%
S&P+12.65%+91.73%+13.89%+2,053%

RadNet Company Info

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$522.87M13.4%
Gross Profit$32.69M-4.9%
Gross Margin6.25%-1.2%
Market Cap$5.86B14.2%
Market Cap / Employee$0.69M0.0%
Employees8.5K8.6%
Net Income$13.89M13.3%
EBITDA$72.49M4.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$804.72M7.5%
Accounts Receivable$210.55M5.8%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$1.76B6.5%
Short Term Debt$85.79M4.5%

Ratios

Q3 2025YOY Change
Return On Assets-0.37%-0.2%
Return On Invested Capital0.25%-0.2%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$41.14M151.9%
Operating Free Cash Flow$101.59M77.0%

Valuation

MetricQ4 2023Q1 2024Q2 2024Q4 2024YoY Change
Price to Earnings38633.33149.82401.362135.78-
Price to Book5.774.084.756.147.03%
Price to Sales2.942.881.982.25-10.74%
Price to Tangible Book Value52.1733.3842.2763.7623.01%
Price to Free Cash Flow TTM55.38117.3647.4656.55-11.17%
Enterprise Value to EBITDA97.89349.3969.5076.61-3.66%
Free Cash Flow Yield1.8%0.9%2.1%1.8%12.58%
Return on Equity0.4%-3.7%-1.6%-1.3%123.26%
Total Debt$1.73B$1.75B$1.84B$1.85B6.38%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.